Variables | M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | ||||||||
OR | SE | OR | SE | OR | SE | OR | SE | OR | SE | OR | SE | OR | SE | OR | SE | |
Age | 1.019 | 0.458 | 1.369 | 0.271 | 1.210 | 0.275 | 1.116 | 0.292 | 1.230 | 0.396 | 1.006 | 0.443 | 1.093 | 0.441 | 1.057 | 0.446 |
Eligible health condition | 2.528** | 0.329 | 3.050*** | 0.204 | 3.079*** | 0.208 | 2.469*** | 0.222 | 2.145** | 0.296 | 2.549** | 0.320 | 2.531** | 0.320 | 2.531** | 0.323 |
Private insurance | 3.463*** | 0.386 | 2.833*** | 0.242 | 2.611*** | 0.246 | 2.197** | 0.265 | 2.394** | 0.337 | 3.062** | 0.367 | 3.269*** | 0.372 | 3.374*** | 0.377 |
Public insurance | 4.507*** | 0.415 | 3.461 | 0.258 | 3.143*** | 0.262 | 2.542*** | 0.282 | 3.163*** | 0.362 | 4.137*** | 0.391 | 4.158*** | 0.391 | 4.273*** | 0.397 |
Gender | 0.916 | 0.269 | 0.913 | 0.166 | 0.948 | 0.171 | 0.859 | 0.185 | 0.907 | 0.240 | 0.931 | 0.253 | 0.867 | 0.257 | 0.898 | 0.259 |
Marital status | 0.672 | 0.294 | 1.093 | 0.185 | 1.062 | 0.188 | 1.032 | 0.204 | 0.890 | 0.266 | 0.743 | 0.281 | 0.759 | 0.283 | 0.728 | 0.286 |
Income | 1.146* | 0.074 | 1.198*** | 0.046 | 1.166** | 0.049 | 1.140** | 0.052 | 1.145** | 0.067 | 1.143* | 0.070 | 1.130* | 0.070 | 1.145* | 0.070 |
Education | 1.052 | 0.095 | 0.740 | 0.182 | 1.036 | 0.062 | 0.983 | 0.067 | 1.025 | 0.088 | 1.046 | 0.093 | 1.042 | 0.093 | 1.035 | 0.093 |
Ethnicity | 0.664 | 0.287 | 1.369* | 0.271 | 0.681** | 0.186 | 0.665** | 0.202 | 0.681 | 0.254 | 0.677 | 0.266 | 0.695 | 0.270 | 0.693 | 0.271 |
Vaccine access | 1.277 | 0.384 | ||||||||||||||
Time to vaccinate | 2.182** | 0.356 | 2.804*** | 0.220 | 2.565*** | 0.239 | 2.417** | 0.303 | 2.194** | 0.319 | 2.535** | 0.329 | 2.432** | 0.331 | ||
Physician’s opinion | 4.361*** | 0.345 | 6.909*** | 0.211 | 2.946*** | 0.276 | 3.700*** | 0.309 | 4.260*** | 0.322 | 4.285*** | 0.321 | ||||
Relatives’ opinion | 0.866 | 0.312 | ||||||||||||||
Vulnerable to influenza | 1.335*** | 0.069 | 1.359*** | 0.056 | 1.291*** | 0.059 | 1.284*** | 0.059 | 1.290*** | 0.060 | ||||||
Susceptible to influenza | 1.013 | 0.056 | ||||||||||||||
Likelihood of catching influenza | 1.235*** | 0.060 | 1.238*** | 0.049 | 1.238*** | 0.055 | 1.226*** | 0.056 | 1.216*** | 0.056 | ||||||
Severity of influenza (bed-days) | 1.121 | 0.126 | ||||||||||||||
Severity of influenza | 0.908* | 0.061 | 0.911* | 0.051 | 0.902* | 0.055 | 0.909* | 0.055 | 0.903** | 0.055 | ||||||
Fear of influenza | 0.973 | 0.063 | ||||||||||||||
Worry of transmitting influenza | 0.932 | 0.056 | ||||||||||||||
Perceived control over influenza | 0.752*** | 0.056 | 0.741*** | 0.047 | 0.757*** | 0.052 | 0.748*** | 0.052 | 0.744*** | 0.052 | ||||||
Regret of catching influenza | 1.165** | 0.054 | 1.112** | 0.043 | 1.117** | 0.049 | 1.126** | 0.049 | 1.122** | 0.050 | ||||||
Perceived knowledge of vaccine | 0.406** | 0.390 | 0.368** | 0.361 | 0.368** | 0.366 | 0.388** | 0.367 | ||||||||
Effectiveness of vaccine | 1.249*** | 0.066 | 1.188** | 0.062 | 1.222** | 0.064 | 1.225*** | 0.064 | ||||||||
Vaccine transmits influenza | 0.848** | 0.054 | 0.827*** | 0.046 | 0.835*** | 0.046 | 0.836*** | 0.047 | ||||||||
Vaccine contents are dangerous | 0.961 | 0.055 | ||||||||||||||
Vaccine is painful | 1.775* | 0.329 | 1.712* | 0.304 | 1.585 | 0.309 | 1.558 | 0.310 | ||||||||
Vaccine-related self-efficacy | 1.010 | 0.053 | ||||||||||||||
Trust in physician (scale) | 0.836* | 0.096 | 0.796** | 0.090 | 0.809** | 0.091 | ||||||||||
Trust in manufacturers | 0.895 | 0.081 | ||||||||||||||
Trust in health authorities | 1.013 | 0.086 | ||||||||||||||
Shared decision-making doctor | 0.953 | 0.147 | ||||||||||||||
Bad experience vaccines—child | 1.449 | 0.417 | ||||||||||||||
Scary health experience—child | 2.126* | 0.464 | 2.153* | 0.450 | ||||||||||||
Number of participants | 724 | 724 | 724 | 724 | 724 | 724 | 724 | 724 | ||||||||
Nagelkerke R | 0.734 | 0.215 | 0.252 | 0.389 | 0.686 | 0.719 | 0.725 | 0.727 |
The change in model fit indicated by χ2 test for each block of variables was always significant (p<0.1). *p<0.1; **p<0.05; ***p<0.001. In bold are the variables significantly associated with vaccination uptake in the final model (M8).